Institution identification

PURI

https://redirect.ema.europa.eu/resource/47832

Institution ID

47832

Institution full name and acronym

Porto Pharmacovigilance Centre, Faculty of Medicine, University of Porto (UFPorto)

Institution countries

Portugal

Type of institution

Educational Institution

Institution website

ENCePP partner

Yes
Institution description
The Porto Pharmacovigilance Centre (UFPorto) is a regional centre of the Portuguese Pharmacovigilance System. This Centre is responsible for the collection,validation,processing and assessment of spontaneous reports of Adverse Drug Reaction in the Porto District,Portugal. UFPortoalso performs research on pharmacovigilance and drug safety.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
No

Contact

Studies conducted by the institution

Impact of EU label changes and pregnancy prevention programme for medicinal products containing valproate and related substances: risk awareness and adherence (ValproateRiskAware)
Impact of EU label changes and regulatory communication on SARS-CoV-2 adenovirus vector vaccines in context of thrombosis with thrombocytopenia syndrome (TTS): risk awareness and adherence (RiskAwareTTS)
Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products: risk awareness and adherence (RetinoidRiskAware)
Implementation of EU risk minimisation measures for medicinal products in clinical guidelines
LOOK-UP: Active pharmacovigilance study of the medicine Rinvoq™ (upadacitinib)
Post-marketing Surveillance Study of the Effectiveness and Safety of new Oral Antivirals for outpatients with mild-moderate COVID-19. (ESOA-19)